Financial Daily from THE HINDU group of publications
Friday, Jul 22, 2005

Port Info

Group Sites

Corporate - Announcements

Ranbaxy gets tentative FDA nod for diabetes drug

Our Bureau

New Delhi , July 21

RANBAXY Laboratories Ltd has received tentative approval from the US Food & Drug Administration (FDA) to manufacture and market Glimepiride tablets 1 mg, 2 mg, 4 mg and 8 mg to lower blood glucose.

The total annual market sales for Glimepiride were $336.6 million. Glimepiride is indicated as an adjunct to diet and exercise to lower the blood glucose in patients with non-insulin-dependent (Type-II) diabetes mellitus (NIDDM).

It is also indicated for use in combination with insulin to lower blood glucose in patients, whose hyperglycemia cannot be controlled by diet and exercise.

In a notice to the Bombay Stock Exchange, Mr Jim Meehan, Vice-President of Sales & Marketing, Ranbaxy Pharmaceuticals Inc said, "We are pleased to receive this tentative approval for Glimepiride tablets. This product represents an interesting opportunity for Ranbaxy. It will be launched following final approval from the FDA on October 6, 2005."

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Industry-R&D linkage programme

GE Commercial to invest $63 m in Ascendas' IT parks fund
Rico Auto ends pact with Ford
Ranbaxy gets tentative FDA nod for diabetes drug
Lupin launches anti-infective in US
Aurobindo gets European approval for APIs
ADAE to invest Rs 2,300 cr in Reliance Capital
GDR era returns for Indian companies
CNOOC's bid for Unocal — Chinese strategy that tests US ideology
Kerala Govt to move Supreme Court against HC order on Coca-Cola plant licence
Reprieve for Essar Oil directors; HC extends stay in Peerless case
Leela group takes over Kovalam hotel; to spare Halcyon Castle
Cement cos keen on tie-up with SAIL — EOIs for plants at Bhilai, Bokaro
Indo-Malaysian venture to set up furniture plant in Chennai
Lanco coke oven plant begins production
NTC, workers reach pact
HAL, Snecma sign pact for joint venture
Suryalata Spinning offers 1:2 bonus
Sharp to launch electronic cash registers soon
Novartis India looking at two product launches in 2007

The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | The Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright 2005, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line